AFP and hepatocellular carcinoma: Although clinical markers such as alpha-fetoprotein (AFP), glutamyl transpeptidase (γ-GT), and lactic dehydrogenase (LDH) have been used in the early diagnosis and therapeutic monitoring of HCC patient, these factors are nonspecific.